familial temporal lobe epilepsy 3
ORPHA: 1637172 Treatments Available
Overview
temporal lobe epilepsy characterized by simple or complex partial seizures often accompanied by intense feelings of deja or altered awareness and that has material basis in variation in the chromosome region 4q13.2-q21.3
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| carbamazepine | oral tablet 200mg, 400mg; extended-release tablet; oral suspension 100mg/5mL | FDA Approved | 11 | 7d |
| Levetiracetam | Oral tablet 250mg, 500mg, 750mg, 1000mg; Oral solution 100mg/mL; IV infusion 500mg/5mL | FDA Approved, EMA Approved | 11 | 3d |
Classification & Codes
Orphanet Code
ORPHA:163717familial temporal lobe epilepsy 3
| Orphanet | ORPHA:163717 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO